MentionFox
Home › funding signals › Edesa Biotech, Inc.
Company · SEC filings

Edesa Biotech, Inc. funding history

Before you sign with, sell to or invest in Edesa Biotech, Inc.

MentionFox check on Edesa Biotech, Inc.: only 2 sources on file so far (checked 10 November 2026). Run a full check before you rely on it. mentionfox.com/c/company/edesa-biotech-inc

Check Edesa Biotech, Inc. before you sign, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Edesa Biotech, Inc.?

Edesa Biotech, Inc. has 2 Form D filings on record, from 2025-02-14 to 2026-06-26. Together its new offerings report $18.50M sold.

Is this your company?

Funding historyFounders and team

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Edesa Biotech, Inc.: Raised $3.50M, Form D filed 2026-06-26
Share on LinkedIn Share on X Download image

Keep reading

More on this company and the records around it.

this company elsewhere on the record

Companies that share a holder

What do you want to do with Edesa Biotech, Inc.?

Is Edesa Biotech, Inc. a real, registered company?

Edesa Biotech, Inc. is a registered filer with the SEC (CIK 1540159) and has filed since 2025-02-14. 2 filings are on record, the latest on 2026-06-26.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Edesa Biotech, Inc.?

Edesa Biotech, Inc.'s filings name Carlo Sistilli, Charles Olson, David Liu and 8 more as its officers, directors or promoters.

How much has Edesa Biotech, Inc. raised?

Its new offerings report $18.50M sold across 2 offerings, as its own filings state.

Run the free check on Edesa Biotech, Inc. →

Based
MARKHAM, ONTARIO, CANADA
Industry group
Biotechnology
Filings
2
Raised (new offerings)
$18.50M

Every filing

FiledTypeAmount soldTotal offeringRecords
2026-06-26New offering
first sale 2026-06-16
$3.50M$3.50Mdetails · SEC filing
2025-02-14New offering
first sale 2025-02-12
$15M$15Mdetails · SEC filing

Want the whole picture on Edesa Biotech, Inc.?

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Edesa Biotech, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Edesa Biotech, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    2 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.

Every figure here is read from Edesa Biotech, Inc.'s own filings with the SEC. The people those filings name are on the team page.

Filings & events

Who owns it

Fundraising filings

5%+ stakes

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for Edesa Biotech, Inc.. With no account yet, you sign up free and land on the result.

On these startup lists

Healthcare and health tech startups Biotech startups

Cite this page

Permanent URL: https://mentionfox.com/company/edesa-biotech-inc
Last updated 2026-11-10
Primary record: SEC filing 1 · SEC filing 2
How much has Edesa Biotech, Inc. raised? $18.50M in 2 SEC filings. MentionFox, 2026-11-10. https://mentionfox.com/company/edesa-biotech-inc